As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some...
SAN DIEGO — Phase 3 data support rilzabrutinib as a potential first-in-class oral Bruton tyrosine kinase (BTK) inhibitor for patients...
SAN DIEGO — Omitting 24-hour urine testing from multiple myeloma response assessments does not compromise accurate tracking of patients' responses...
SAN DIEGO — The addition of the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy greatly boosted 3-year disease-free survival (DFS)...
SAN DIEGO — Patients with multiple myeloma who receive intravenous immunoglobulin (IVIG) prophylaxis during treatment with teclistamab have fewer infections...
SAN DIEGO — Recipients of allogeneic hematopoietic cell transplantation (allo-HCT) for blood disorders who maintain diets high in fiber show...
The following story contains spoilers for Yellowstone season 5, episode 13, "Give The World Away."WELL, WELL, WELL. With two episodes...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Psychiatry > Anxiety & Stress — BNC210 benefits kicked in as early as 4 weeks by Michael DePeau-Wilson, Enterprise &...
Perspectives > What We Heard This Week — Quotable quotes heard by MedPage Today's reporters by MedPage Today Staff December...
Meeting Coverage > ASH: Hematology — Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies by Ian Ingram, Managing Editor, MedPage Today...
Meeting Coverage > ASH: Hematology — Two-thirds of phase II patients had a complete response at 12 weeks of treatment...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Meeting Coverage > ASH: Hematology — High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors by Charles...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
You must admit that with Christmas around the corner, the folks keeping our food supply safe may well be on...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine...
